Resources - COVID-19 information

Section dedicated to information on pharmacovigilance of medicinal products used to treat and prevent COVID-19 (coronavirus).

The section is divided into two parts: one part relating to links to national and international institutional websites on SARS-CoV-2 (COVID-19) and another part relating to important research documents and initiatives from ISoP members and others.
This page will be regularly updated.

COVID-19 Resources

Here you will find some links to national and international institutional websites and published papers on COVID-19. Stay informed with the latest clinical research and resources.

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSID	session	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
__stripe_mid	1 year	Stripe sets this cookie cookie to process payments.
__stripe_sid	30 minutes	Stripe sets this cookie cookie to process payments.

Cookie	Duration	Description
CONSENT	2 years	YouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
vuid	2 years	Vimeo installs this cookie to collect tracking information by setting a unique ID to embed videos to the website.
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.

Cookie	Duration	Description
NID	6 months	NID cookie, set by Google, is used for advertising purposes; to limit the number of times the user sees an ad, to mute unwanted ads, and to measure the effectiveness of ads.
VISITOR_INFO1_LIVE	5 months 27 days	A cookie set by YouTube to measure bandwidth that determines whether the user gets the new or old player interface.
YSC	session	YSC cookie is set by Youtube and is used to track the views of embedded videos on Youtube pages.
yt-remote-connected-devices	never	YouTube sets this cookie to store the video preferences of the user using embedded YouTube video.
yt-remote-device-id	never	YouTube sets this cookie to store the video preferences of the user using embedded YouTube video.

Resources - COVID-19 information

COVID-19 Resources

World Health Organization

Centers for Disease Control and Prevention

National Institute of Health

European Medicines Agency

COVID-19 data sources (Knowledge Portal on Innovation and Access to Medicines)

The Lancet

The New England Journal Of Medicine

Oxford Covid-19 Evidence service

The Royal College of Obstetricians and Gynaecologists (RCOG)

Italian Society of Pharmacology - English COVID-19 section

JAMA Network

International Union of Pharmacology and Clinical Pharmacology (IUPHAR)

NIPH-Live map of COVID-19 evidence

Springer Nature

The International Coalition of Medicines Regulatory Authorities (ICMRA)

Safety Monitoring Using WHO Global Database of Individual Case Safety Reports (ICSRs). Descriptive analysis of spontaneous report from VigiBase

Indian Council of Medical Research updated ethical guidance for biomedical and health research

African Vaccine Regulatory Forum (AVAREF) tools for Processing clinical trial applications by Ethics Committees and National Regulatory Authorities in Africa

Landscape of COVID-19 candidate vaccines/Draft

WHO Covid-19 vaccine safety manual

The Vaccine Centre & London School of Hygiene & Tropical Medicine

NZ Pharmacovigilance Centre Project encouraging feedback on COVID-19 Medication Safety Challenges in NZ

Johns Hopkins University-Coronavirus Resource Center

ISoP Member Papers and initiatives

Official statement of the section of Clinical Pharmacology of the Italian Society of Pharmacology on the use of ACE- inhibitors or angiotensin receptor blockers in COVID-19 infection with commentary.

Official Statement of the section of Clinical Pharmacology of Italian Society of Pharmacology on Non-steroidal anti-inflammatory drugs (NSAIDs) and the increased risk of complications during infections with commentary.

Simplified description of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Viral lifecycle and drug repurposing strategies.

Benefit-Risk evaluation for Remdesivir in COVID-19.

The challenging times and opportunities for pharmacovigilance in Africa during the COVID‑19 pandemic.

ISoP infographic ‘Using Medicines Safely during the COVID-19 pandemic’. This infographic is aimed at patients and caregivers - feel free to display it in hospitals, clinics, pharmacies and any other public spaces appropriate to where medicines are obtained in your country.

Posibles terapias para COVID-19: revision narrativa de seguridad I. Cloroquina / hidroxicloroquina y azitromicina.

Convalescent plasma in treatment of COVID-19 A review of evidence for a living systematic benefit-risk assessment.

Systematic benefit-risk assessment for the use of CQ or HCQ as a treatment for COVID-19.

Postmarketing studies can they provide a safety net for COVID-19 vaccines in the UK.

How To Investigate A Serious Adverse Event Reporting during Clinical Trial for a COVID-19 vaccine.

What is the difference between observed association and causal association, signals and evidence.

Lopinavir Ritonavir in the Treatment of COVID-19 A dynamic systemative benefit risk assessment.

DSRU Global Pharmacovigilance Observatory. Dissemination of evidence reviews about the safety of medicines and vaccines from around the world.

Challenges for drug repurposing in the COVID-19 pandemic era.

COVID vaccines - Questions & Answers from ISoP Israel Task Force.

ISoP infographic ‘COVID-19 Vaccine Safety'. This infographic is aimed at patients and caregivers - feel free to display it in hospitals, clinics, pharmacies and any other public spaces appropriate to where medicines are obtained in your country.

Guide For the development of pharmacovigilance & Guideline On good pharmacovigilance practices in the context SARS-CoV-2 (COVID-19).